[Supplementary Agreement to Earnest Money Agreement By and between Sanpower Group Co., Ltd., And Golden Meditech Holdings Limited Dated October 2016 1 Supplementary Execution Date This supplementary agreement (this (1) Sanpower (2) Golden Meditech Party Parties Each of Sanpower and Golden Meditech ]
[Supplementary Agreement to Earnest Money Agreement By and between Sanpower Group Co., Ltd., And Golden Meditech Holdings Limited Dated October 2016 1 Supplementary Execution Date This supplementary agreement (this (1) Sanpower (2) Golden Meditech Party Parties Each of Sanpower and Golden Meditech ]
[FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHINA CORD BLOOD CORPORATION Cayman Islands Not Applicable (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) th 48 Law Debenture Corporate Services, Inc. (Name, address and telephone number of agent for service) with a copy to: Mitchell S. Nussbaum, Esq. From time to time after the] [21 September 2016 Matter No.: 822741 Doc Ref: RJH/102777384v1 Tel No.: 852 2842 9530 E-mail: Richard.Hall@conyersdill.com China Cord Blood Corporation 48 th 1 Garden Road, Central Hong Kong S.A.R. Dear Sirs, Re: China Cord Blood Corporation (the Company) Registration Statement Commission Securities Act Ordinary Shares Preferred Shares Equity Securities Debt Securities Rights Units Securities We have acted as special Cayman] [345 Park Avenue New York, NY 10154-1895 Direct Main Fax September 21, 2016 China Cord Blood Corporation 48 th 1 Garden Road Central, Hong Kong, S.A.R. Re: Registration Statement on Form F-3 Ladies and Gentlemen: China Cord Blood Corporation September 21, 2016 Page 2] [RATIO OF EARNINGS TO FIXED CHARGES CCBCs ratio of earnings to fixed charges for each of the periods indicated is set forth below. We have derived the ratios of earnings to fixed charges from our historical consolidated financial statements. The ratios should be read in conjunction with our consolidated financial statements, including the notes thereto, and the other financial information] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31, 2015, and the related consolidated statements of comprehensive income, changes in equity, and cash flows] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31, 2016, and the related consolidated statements of comprehensive income, changes in equity, and cash flows] [China Cord Blood Corporation Central Hong Kong S.A.R. Madams and Sirs, EX-23.5 7 a16-18402_1ex23d5.htm EX-23.5]
[FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHINA CORD BLOOD CORPORATION Cayman Islands Not Applicable (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) th 48 Law Debenture Corporate Services, Inc. (Name, address and telephone number of agent for service) with a copy to: Mitchell S. Nussbaum, Esq. From time to time after the] [21 September 2016 Matter No.: 822741 Doc Ref: RJH/102777384v1 Tel No.: 852 2842 9530 E-mail: Richard.Hall@conyersdill.com China Cord Blood Corporation 48 th 1 Garden Road, Central Hong Kong S.A.R. Dear Sirs, Re: China Cord Blood Corporation (the Company) Registration Statement Commission Securities Act Ordinary Shares Preferred Shares Equity Securities Debt Securities Rights Units Securities We have acted as special Cayman] [345 Park Avenue New York, NY 10154-1895 Direct Main Fax September 21, 2016 China Cord Blood Corporation 48 th 1 Garden Road Central, Hong Kong, S.A.R. Re: Registration Statement on Form F-3 Ladies and Gentlemen: China Cord Blood Corporation September 21, 2016 Page 2] [RATIO OF EARNINGS TO FIXED CHARGES CCBCs ratio of earnings to fixed charges for each of the periods indicated is set forth below. We have derived the ratios of earnings to fixed charges from our historical consolidated financial statements. The ratios should be read in conjunction with our consolidated financial statements, including the notes thereto, and the other financial information] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31, 2015, and the related consolidated statements of comprehensive income, changes in equity, and cash flows] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31, 2016, and the related consolidated statements of comprehensive income, changes in equity, and cash flows] [China Cord Blood Corporation Central Hong Kong S.A.R. Madams and Sirs, EX-23.5 7 a16-18402_1ex23d5.htm EX-23.5]
[Confidential Earnest Money Agreement Agreement This earnest money agreement (this (1) Sanpower (2) Golden Meditech Each of Sanpower and Golden Meditech is referred to as a Party, and collectively the Parties. Whereas, (A) Nanjing Xinjiekou China Cord SPA APA Existing Transaction Plan (B) Alternative Transaction Plan (C) Therefore, the Parties agree as follows: 1. 1 2. 3. 4. 5.] []
[Confidential Earnest Money Agreement Agreement This earnest money agreement (this (1) Sanpower (2) Golden Meditech Each of Sanpower and Golden Meditech is referred to as a Party, and collectively the Parties. Whereas, (A) Nanjing Xinjiekou China Cord SPA APA Existing Transaction Plan (B) Alternative Transaction Plan (C) Therefore, the Parties agree as follows: 1. 1 2. 3. 4. 5.] []
[China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2017 1Q17 Added 16,637 New Subscribers 1Q17 Revenue Up 4.6% YOY to RMB173.0 Million ($26.0 Million) 1Q17 Operating Income Up 7.7% YOY to RMB52.1 Million ($7.8 Million) Conference Call to be Held on August 23, 2016 at 8:00 a.m. ET HONG KONG, China, August 22, 2016 ] [FORM 6-K For the month of August 2016 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Form 20-F x o o o Yes o x EXPLANATORY NOTE 2 Results of Operations and Financial Condition Following this cover page are the unaudited condensed consolidated financial results for the three months ended June 30, 2016 of the Company. 3]
[China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2017 1Q17 Added 16,637 New Subscribers 1Q17 Revenue Up 4.6% YOY to RMB173.0 Million ($26.0 Million) 1Q17 Operating Income Up 7.7% YOY to RMB52.1 Million ($7.8 Million) Conference Call to be Held on August 23, 2016 at 8:00 a.m. ET HONG KONG, China, August 22, 2016 ] [FORM 6-K For the month of August 2016 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Form 20-F x o o o Yes o x EXPLANATORY NOTE 2 Results of Operations and Financial Condition Following this cover page are the unaudited condensed consolidated financial results for the three months ended June 30, 2016 of the Company. 3]
